Literature DB >> 9010409

Pseudotumour cerebri syndrome due to cryptococcal meningitis.

P D Cremer1, I H Johnston, G M Halmagyi.   

Abstract

Three cases are reported of the pseudotumour cerebri syndrome-that is, intracranial hypertension without mass lesion or enlarged ventricles, due to cryptococcal meningitis. In these patients the papilloedema was successfully treated with optic nerve sheath decompression, and the intracranial hypertension with lumboperitoneal CSF shunting. These cases support the concept that pseudotumour cerebri is a syndrome of intracranial hypertension that can be due to any disorder producing obstruction of the CSF pathways at the level of the arachnoid villi. This concept is important because it directs therapy to normalise the intracranial pressure and preserve vision.

Entities:  

Mesh:

Year:  1997        PMID: 9010409      PMCID: PMC486704          DOI: 10.1136/jnnp.62.1.96

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  12 in total

1.  DIAGNOSTIC AND PROGNOSTIC VALUE OF CLINICAL AND LABORATORY FINDINGS IN CRYPTOCOCCAL MENINGITIS, A FOLLOW-UP STUDY OF FORTY PATIENTS.

Authors:  W T BUTLER; D W ALLING; A SPICKARD; J P UTZ
Journal:  N Engl J Med       Date:  1964-01-09       Impact factor: 91.245

2.  The pseudotumor syndrome. Disorders of cerebrospinal fluid circulation causing intracranial hypertension without ventriculomegaly.

Authors:  I Johnston; S Hawke; M Halmagyi; C Teo
Journal:  Arch Neurol       Date:  1991-07

3.  Cerebral venography and manometry in idiopathic intracranial hypertension.

Authors:  J O King; P J Mitchell; K R Thomson; B M Tress
Journal:  Neurology       Date:  1995-12       Impact factor: 9.910

4.  Cerebral torulosis: clinical features and correlation with computed tomography.

Authors:  N Daunt; L S Jayasinghe
Journal:  Clin Radiol       Date:  1985-09       Impact factor: 2.350

5.  Raised intracranial pressure and visual complications in AIDS patients with cryptococcal meningitis.

Authors:  S R Johnston; E L Corbett; O Foster; S Ash; J Cohen
Journal:  J Infect       Date:  1992-03       Impact factor: 6.072

6.  Ventriculoperitoneal shunt in cryptococcal meningitis with hydrocephalus.

Authors:  L M Tang
Journal:  Surg Neurol       Date:  1990-05

Review 7.  Catastrophic visual loss due to Cryptococcus neoformans meningitis.

Authors:  J H Rex; R A Larsen; W E Dismukes; G A Cloud; J E Bennett
Journal:  Medicine (Baltimore)       Date:  1993-07       Impact factor: 1.889

8.  Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies.

Authors:  D G Karahalios; H L Rekate; M H Khayata; P J Apostolides
Journal:  Neurology       Date:  1996-01       Impact factor: 9.910

9.  Cryptococcus meningitis, clinical--CT scan considerations.

Authors:  C T Tan; B B Kuan
Journal:  Neuroradiology       Date:  1987       Impact factor: 2.804

10.  Intracranial hypertension causing visual failure in cryptococcus meningitis.

Authors:  C T Tan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-07       Impact factor: 10.154

View more
  3 in total

1.  The Pseudotumor Cerebri Syndrome: A Unifying Pathophysiological Concept for Patients with Isolated Intracranial Hypertension with Neither Mass Lesion Nor Ventriculomegaly.

Authors:  G M Halmagyi; R M Ahmed; I H Johnston
Journal:  Neuroophthalmology       Date:  2014-07-24

2.  Rapidly progressive dementia and ataxia in an elderly man.

Authors:  Rebekah M Ahmed; G Michael Halmagyi; Michael L Rodriguez
Journal:  Pract Neurol       Date:  2013-03-13

3.  CryptoDex: a randomised, double-blind, placebo-controlled phase III trial of adjunctive dexamethasone in HIV-infected adults with cryptococcal meningitis: study protocol for a randomised control trial.

Authors:  Jeremy Day; Darma Imran; Ahmed Rizal Ganiem; Natriana Tjahjani; Retno Wahyuningsih; Robiatul Adawiyah; David Dance; Mayfong Mayxay; Paul Newton; Rattanaphone Phetsouvanh; Sayaphet Rattanavong; Adrienne K Chan; Robert Heyderman; Joep J van Oosterhout; Wirongrong Chierakul; Nick Day; Anatoli Kamali; Freddie Kibengo; Eugene Ruzagira; Alastair Gray; David G Lalloo; Justin Beardsley; Tran Quang Binh; Tran Thi Hong Chau; Nguyen Van Vinh Chau; Ngo Thi Kim Cuc; Jeremy Farrar; Tran Tinh Hien; Nguyen Van Kinh; Laura Merson; Lan Phuong; Loc Truong Tho; Pham Thanh Thuy; Guy Thwaites; Heiman Wertheim; Marcel Wolbers
Journal:  Trials       Date:  2014-11-12       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.